Drug:
Reaction: INFLUENZA
20260101 - 20261231
No. 401 - 500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 401 | 26820236 |
US |
61 | 2 |
Abdominal distension, Back pain, Abdominal pain upper, Influenza, Inappropriate schedule of product administration, |
||||
MEPOLIZUMAB, |
||||
| 402 | 26820409 |
US |
5 | 2 |
Influenza, |
||||
TROFINETIDE, |
||||
| 403 | 26821113 |
AR |
53 | 1 |
Thrombosis, Influenza, Acne, Therapy interrupted, Hypersensitivity, Malaise, |
||||
PANITUMUMAB, PANITUMUMAB, |
||||
| 404 | 26821791 |
US |
71 | 1 |
Tremor, Dizziness postural, Influenza, Diarrhoea, Dizziness, Injection site nodule, Headache, Somnolence, Injection site pain, |
||||
APOMORPHINE HYDROCHLORIDE, APOMORPHINE HYDROCHLORIDE, APOMORPHINE HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, RASAGILINE MESYLATE, RASAGILINE, |
||||
| 405 | 26823236 |
CA |
67 | 2 |
Myocardial infarction, Pneumonia, Illness, Confusional state, Influenza, Inappropriate schedule of product administration, |
||||
INCLISIRAN, INCLISIRAN, |
||||
| 406 | 26823743 |
BR |
2 | |
Influenza, Lymphadenopathy, Asthma, Pain, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 407 | 26824804 |
EU |
||
COVID-19, Toothache, Mouth ulceration, Aspartate aminotransferase increased, Alanine aminotransferase increased, Influenza, Arthralgia, |
||||
INFLIXIMAB, INFLIXIMAB, |
||||
| 408 | 26824862 |
US |
41 | 2 |
Influenza, Migraine, Asthma, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 409 | 26824927 |
BR |
14 | 1 |
Colitis ulcerative, Influenza, Weight increased, Drug intolerance, Loss of therapeutic response, Off label use, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 410 | 26827407 |
|||
Dizziness, Vertigo, Vomiting, Nausea, Loss of consciousness, Influenza, Sinusitis, |
||||
ADALIMUMAB-ADAZ, |
||||
| 411 | 26827434 |
2 | ||
Influenza, |
||||
PEMIGATINIB, |
||||
| 412 | 26818126 |
US |
35 | 1 |
Influenza, Gastroenteritis viral, |
||||
DUPILUMAB, |
||||
| 413 | 26818208 |
US |
1 | |
Chronic obstructive pulmonary disease, Ill-defined disorder, Influenza, |
||||
EVOLOCUMAB, |
||||
| 414 | 26818591 |
US |
45 | 2 |
Influenza, |
||||
TIRZEPATIDE, |
||||
| 415 | 26818633 |
US |
2 | |
Dyspnoea, Wheezing, Nasal congestion, Influenza, Asthma, Drug ineffective, |
||||
DUPILUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, MEPOLIZUMAB, PREDNISONE, PROGESTERONE, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE INHALATION SPRAY, |
||||
| 416 | 26819091 |
US |
1 | |
Respiratory syncytial virus infection, Influenza, |
||||
TIRZEPATIDE, |
||||
| 417 | 26819164 |
GB |
||
Influenza, Thrombocytopenia, Eye symptom, Inappropriate schedule of product administration, |
||||
BELANTAMAB MAFODOTIN, |
||||
| 418 | 26819223 |
US |
68 | 2 |
Influenza, Fatigue, Asthenia, Fall, Pain, Contusion, |
||||
SPARSENTAN, SPARSENTAN, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, DAPAGLIFLOZIN, |
||||
| 419 | 26813295 |
CA |
52 | |
Cellulitis, Illness, Asthenia, Influenza, Pneumonia, Pain in extremity, Arthralgia, Off label use, Inappropriate schedule of product administration, Intentional product use issue, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
| 420 | 26813497 |
CO |
73 | 2 |
Cataract, Influenza, |
||||
DUPILUMAB, |
||||
| 421 | 26813648 |
CO |
67 | 2 |
Neuropathy peripheral, Dizziness, Influenza, Asthenia, Decreased immune responsiveness, Vasculitis, Pain in extremity, Thyroid disorder, Urinary tract infection, Blood cholesterol increased, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 422 | 26813744 |
CA |
67 | 2 |
Dizziness, Hypertension, Nausea, Disturbance in attention, Hypotension, Blood glucose decreased, Headache, Influenza, Malaise, Lethargy, Restless legs syndrome, |
||||
AMLODIPINE, |
||||
| 423 | 26813910 |
US |
2 | |
Influenza, Therapy cessation, Device failure, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 424 | 26814182 |
US |
2 | |
Influenza, Pneumonia, |
||||
ABEMACICLIB, |
||||
| 425 | 26814413 |
US |
2 | |
Influenza, Platelet count decreased, Vomiting, Fall, Brain fog, White blood cell count decreased, Head injury, Nausea, Blood test abnormal, Tumour lysis syndrome, |
||||
VENETOCLAX, VENETOCLAX, |
||||
| 426 | 26814496 |
EU |
1 | |
Lumbar vertebral fracture, Influenza, Taste disorder, Fatigue, |
||||
BORTEZOMIB, BORTEZOMIB, SELINEXOR, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ACYCLOVIR, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 427 | 26814578 |
EU |
25 | 2 |
Granuloma, Rash, Abdominal pain lower, Fatigue, Terminal ileitis, Gastritis, Ileal ulcer, Large intestinal ulcer, Rectal ulcer, Lymphadenopathy, Mesenteritis, C-reactive protein increased, Inflammation, Influenza, Rhinitis, Nasal discharge discolouration, Platelet count increased, Eosinophil count increased, Monocyte count increased, Alanine aminotransferase increased, Gamma-glutamyltransferase increased, Epstein-Barr virus antibody positive, Varicella virus test positive, Pyrexia, |
||||
DUPILUMAB, |
||||
| 428 | 26814632 |
US |
72 | 1 |
Pneumonia, Cough, Headache, Influenza, Flushing, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, ESCITALOPRAM OXALATE, ESCITALOPRAM, PANTOPRAZOLE SODIUM, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, NITROGLYCERIN, PREDNISONE, OXYGEN, 0XYGEN, FUROSEMIDE, NINTEDANIB, NASAL, SODIUM CHLORIDE, SALINE, SALINE NASAL SPRAY, (SALINE), |
||||
| 429 | 26815075 |
CA |
61 | 2 |
Cardiac disorder, Pneumonia, Influenza, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, CHOLESTYRAMINE, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, ATORVASTATIN CALCIUM, |
||||
| 430 | 26815477 |
US |
1 | |
Headache, Chills, Hot flush, Chromaturia, Influenza, Hypoglycaemia, Nausea, Fatigue, Frequent bowel movements, |
||||
TIRZEPATIDE, |
||||
| 431 | 26816239 |
35 | 2 | |
Blindness, Iridocyclitis, Vision blurred, Gait disturbance, Pain, Swelling face, Influenza, Asthenia, Product dose omission issue, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 432 | 26816593 |
US |
74 | 2 |
Influenza, |
||||
LENALIDOMIDE, |
||||
| 433 | 26816860 |
82 | 2 | |
Influenza, Renal disorder, |
||||
LENALIDOMIDE, |
||||
| 434 | 26816973 |
US |
||
Illness, COVID-19, Herpes zoster, Influenza, Immune system disorder, |
||||
INFLIXIMAB, |
||||
| 435 | 26817537 |
EU |
67 | |
Influenza, Acute kidney injury, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, BEVACIZUMAB, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CARBOPLATIN, |
||||
| 436 | 26822116 |
1 | ||
Influenza, Chronic obstructive pulmonary disease, |
||||
APREMILAST, |
||||
| 437 | 26809309 |
CO |
63 | 2 |
Blood gases abnormal, Cardiac tamponade, Influenza, Oxygen saturation decreased, Dizziness, Purulent discharge, Syncope, Heart rate decreased, Blood cholesterol increased, Dysphonia, Blood triglycerides increased, |
||||
ROMOSOZUMAB-AQQG, ROMOSOZUMAB-AQQG, |
||||
| 438 | 26809860 |
US |
4 | 1 |
Viral infection, Influenza, |
||||
DUPILUMAB, |
||||
| 439 | 26810063 |
61 | 2 | |
Influenza, Headache, Malaise, Rash, |
||||
SIMVASTATIN, ATORVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, |
||||
| 440 | 26810144 |
CA |
1 | |
Crohn^s disease, Psoriasis, Influenza, Off label use, Product distribution issue, Insurance issue, Inappropriate schedule of product administration, |
||||
ADALIMUMAB-RYVK, ADALIMUMAB-RYVK, |
||||
| 441 | 26810705 |
US |
2 | |
Eosinophil count increased, Illness, Influenza, Rash, |
||||
DUPILUMAB, ALBUTEROL SULFATE, CLARITHROMYCIN, DEXTROAMPHETAMINE, ETHAMBUTOL HYDROCHLORIDE, ETHAMBUTOL HYDROCHLORIDE, FLUTICASONE PROPIONATE, FLUOXETINE HYDROCHLORIDE, FLUTICASONE PROPIONATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, UMECLIDINIUM, LORATADINE, LORATADINE ORAL, NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, OLOPATADINE HYDROCHLORIDE, OLOPATADINE HYDROCHLORIDE OPHTHALMIC, OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, RIFAMPIN, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 442 | 26810827 |
61 | 2 | |
Influenza, Myalgia, Headache, Malaise, Muscle spasms, |
||||
SIMVASTATIN, ROSUVASTATIN CALCIUM, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, |
||||
| 443 | 26811232 |
CA |
2 | |
Feeling abnormal, Pneumonia, Decreased immune responsiveness, Thrombosis, Influenza, Ill-defined disorder, |
||||
SECUKINUMAB, |
||||
| 444 | 26811249 |
US |
65 | 2 |
Right ventricular failure, Chest pain, Influenza, Oedema, Peripheral swelling, Chest discomfort, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FOLIC ACID, PRAVASTATIN SODIUM, PANTOPRAZOLE SODIUM, SILDENAFIL CITRATE, SILDENAFIL, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, MACITENTAN, OXYGEN, 0XYGEN, ERGOCALCIFEROL, SPIRONOLACTONE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, SEVELAMER CARBONATE, SODIUM BICARBONATE, SODIUM BICARBONATE, INJECTION, SODIUM BICARBONATE INJECTION,, FERROUS SULFATE, FUROSEMIDE, FUROSEMIDE, |
||||
| 445 | 26811250 |
US |
2 | |
Influenza, Infusion site swelling, Infusion site rash, Device infusion issue, |
||||
TREPROSTINIL, TREPROSTINIL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, FAMOTIDINE, MUPIROCIN, MUPIROCIN CALCIUM, LANSOPRAZOLE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, PROPRANOLOL HYDROCHLORIDE, OXYGEN, 0XYGEN, SPIRONOLACTONE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, IPRATROPIUM BROMIDE, HYDROCHLOROTHIAZIDE, LEVALBUTEROL TARTRATE, BETHANECHOL CHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, SILDENAFIL CITRATE, SILDENAFIL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, FUROSEMIDE, AMBRISENTAN, VANCOMYCIN HYDROCHLORIDE, |
||||
| 446 | 26811371 |
GB |
45 | 2 |
Lower respiratory tract infection, Influenza, Malaise, Upper respiratory tract infection, |
||||
| 447 | 26811427 |
CA |
83 | 2 |
Back pain, Fatigue, Influenza, Pulmonary embolism, Off label use, |
||||
RITUXIMAB, RITUXIMAB, |
||||
| 448 | 26811554 |
US |
14 | |
Influenza, |
||||
BUROSUMAB, |
||||
| 449 | 26812110 |
US |
75 | 2 |
Arthralgia, Influenza, |
||||
DUPILUMAB, |
||||
| 450 | 26812181 |
CA |
67 | 2 |
Death, Wrong technique in product usage process, Drug dose omission by device, Anxiety, Accidental exposure to product, Injection site pain, Device difficult to use, Hyperhidrosis, Dysphonia, Influenza, Device use issue, |
||||
FREMANEZUMAB-VFRM, TOPIRAMATE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 451 | 26812509 |
JP |
7 | 1 |
Drug level increased, Dyspnoea, Pneumonia bacterial, Influenza, Throat tightness, |
||||
VORICONAZOLE, VORICONAZOLE INJECTION, VORICONAZOLE, VORICONAZOLE INJECTION, VORICONAZOLE, VORICONAZOLE INJECTION, WARFARIN, FUROSEMIDE, TOLVAPTAN, CLARITHROMYCIN, AZILSARTAN KAMEDOXOMIL, AMLODIPINE, |
||||
| 452 | 26812910 |
GB |
35 | 2 |
Multiple sclerosis, Pain, Asthenia, Muscle spasms, Appendicitis, Lower respiratory tract infection, Urinary tract infection, Fatigue, Dysuria, Blood urine present, Pollakiuria, Abdominal pain, Back pain, Ear infection, Influenza, Malaise, |
||||
OFATUMUMAB, OFATUMUMAB, |
||||
| 453 | 26812957 |
US |
22 | 1 |
Influenza, Conjunctivitis, Ocular hyperaemia, Eye discharge, Hyperhidrosis, |
||||
DUPILUMAB, |
||||
| 454 | 26813010 |
US |
64 | 2 |
COVID-19, Pneumonia, Loss of consciousness, Brain injury, Adverse drug reaction, Influenza, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 455 | 26816350 |
2 | ||
Therapy non-responder, Pain, Loss of personal independence in daily activities, Infection, Therapy interrupted, Malaise, Nasopharyngitis, Influenza, |
||||
CERTOLIZUMAB PEGOL, DUPILUMAB, PREDNISONE, |
||||
| 456 | 26803704 |
US |
71 | 2 |
Diabetes mellitus inadequate control, Pancreatitis, Pain in extremity, Tinnitus, Vaginal haemorrhage, Weight decreased, Nasopharyngitis, Conjunctivitis, Influenza, |
||||
TEPROTUMUMAB, |
||||
| 457 | 26803800 |
US |
2 | |
Influenza, |
||||
DUPILUMAB, |
||||
| 458 | 26803892 |
CA |
3 | |
Immunosuppression, Post transplant lymphoproliferative disorder, Influenza, Warm autoimmune haemolytic anaemia, Epstein-Barr virus infection reactivation, Drug effective for unapproved indication, Off label use, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, CYCLOSPORINE, ETOPOSIDE, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 459 | 26804178 |
EU |
2 | |
Pneumonia, Therapeutic response unexpected, Influenza, |
||||
EVOLOCUMAB, BEMPEDOIC ACID, |
||||
| 460 | 26804184 |
VN |
6 | 1 |
Pneumocystis jirovecii pneumonia, Acute kidney injury, Thrombocytopenia, Neutropenia, Dengue fever, Cytomegalovirus infection reactivation, Parotitis, Influenza, Rhinitis, Pharyngitis, |
||||
BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, POMALIDOMIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 461 | 26804383 |
BR |
44 | |
Headache, Cough, Asthenia, Malaise, Pyrexia, Rhinalgia, Decreased immune responsiveness, Chills, Feeling cold, Influenza, |
||||
RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, |
||||
| 462 | 26805134 |
NZ |
2 | |
Herpes zoster, Intestinal perforation, Influenza, Drug hypersensitivity, Sinus disorder, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 463 | 26805166 |
AU |
56 | 1 |
Influenza, Walking aid user, |
||||
OCRELIZUMAB, TELMISARTAN, |
||||
| 464 | 26805281 |
US |
44 | 1 |
Influenza, Eczema, |
||||
DUPILUMAB, |
||||
| 465 | 26805426 |
MX |
10 | |
Hypothermia, Nasal congestion, Limb discomfort, Nasopharyngitis, Pain, Influenza, Pyrexia, Rhinorrhoea, Hypersensitivity, |
||||
PALIVIZUMAB, PALIVIZUMAB, FOLIC ACID, IRON, VITAMIN E, |
||||
| 466 | 26805572 |
GB |
23 | 2 |
Syncope, Influenza, |
||||
RAVULIZUMAB, |
||||
| 467 | 26805840 |
EU |
||
Pneumonia, Haematological infection, Septic shock, Infection, Acinetobacter infection, Pseudomonas infection, Achromobacter infection, Klebsiella infection, Respiratory tract infection viral, COVID-19, Influenza, Cytomegalovirus infection, Aspergillus infection, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 468 | 26806744 |
US |
75 | 2 |
Breast cancer, Amnesia, Influenza, Illness, Asthenia, Depression, Weight decreased, Muscular weakness, Bone loss, Bone pain, Insurance issue, |
||||
ASFOTASE ALFA, LETROZOLE, LETROZOLE TABLETS, |
||||
| 469 | 26807509 |
2 | ||
Influenza, |
||||
REPOSITORY CORTICOTROPIN, REPOSITORY CORTICOTROPIN, |
||||
| 470 | 26808653 |
US |
74 | 2 |
Influenza, Atrial fibrillation, Dizziness, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 471 | 26811205 |
78 | 1 | |
Urinary tract infection, Influenza, |
||||
LENALIDOMIDE, |
||||
| 472 | 26798403 |
CA |
32 | 2 |
Pneumonia, Nasal discharge discolouration, Blood pressure increased, Vertigo, Full blood count abnormal, Drug ineffective, Urticaria, Cough, Terminal insomnia, Decreased activity, Abdominal pain, Influenza, Product administration error, Heart rate increased, Urinary tract infection, Asthma, Oropharyngeal pain, Therapeutic product effect decreased, Bacterial infection, Wheezing, Fungal infection, Pain, Emphysema, Sinusitis, Feeding disorder, Dyspnoea exertional, Anxiety, Middle insomnia, Malaise, Stress, Vomiting, Nasal congestion, Eczema, Sleep disorder, Diarrhoea, Loss of personal independence in daily activities, Migraine, Musculoskeletal chest pain, Restrictive pulmonary disease, Dizziness, Tooth abscess, Nasopharyngitis, Obstructive airways disorder, Upper-airway cough syndrome, Sleep disorder due to a general medical condition, Infection, Eosinophil count abnormal, Ear infection, Therapeutic response decreased, Rales, Tachycardia, Dyspnoea, Psoriasis, Forced expiratory volume decreased, Productive cough, Rhinitis, |
||||
FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MONTELUKAST SODIUM, MONTELUKAST, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, TERBUTALINE SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, IPRATROPIUM BROMIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, MEPOLIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMLODIPINE, CICLESONIDE, MONTELUKAST SODIUM, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, EPINEPHRINE, EPINEPHRINE, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 473 | 26799484 |
CA |
48 | |
Immunodeficiency, Tooth extraction, Shoulder operation, Gingivitis, Nasopharyngitis, Influenza, Intentional dose omission, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, FOLIC ACID, SULFASALAZINE, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 474 | 26799501 |
US |
75 | 1 |
Illness, Abdominal pain, Therapeutic product effect incomplete, Disease risk factor, Tremor, Oxygen saturation decreased, Lung disorder, Fall, Influenza, Concussion, Head injury, Dysstasia, Gait inability, |
||||
UPADACITINIB, UPADACITINIB, PSYLLIUM HUSK, |
||||
| 475 | 26799844 |
US |
81 | 2 |
Nasopharyngitis, Influenza, Diarrhoea, Back pain, Myalgia, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 476 | 26799869 |
CA |
48 | |
Lower respiratory tract infection, Pneumonia, Influenza, Inappropriate schedule of product administration, Therapeutic response shortened, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, BUDESONIDE, FLUTICASONE FUROATE, MONTELUKAST, |
||||
| 477 | 26800073 |
EU |
57 | 2 |
Small intestinal haemorrhage, Gastrointestinal pain, Influenza, |
||||
RISANKIZUMAB-RZAA, |
||||
| 478 | 26800124 |
US |
45 | 2 |
Swelling face, Erythema, Feeling hot, Lymphadenopathy, Influenza, |
||||
ASFOTASE ALFA, ASFOTASE ALFA, |
||||
| 479 | 26800553 |
|||
Headache, Somnolence, Pruritus, Illness, Pyrexia, Fatigue, Dyspnoea, Fall, Inappropriate schedule of product administration, Musculoskeletal stiffness, Influenza, Therapeutic product effect incomplete, Myalgia, Diplopia, |
||||
ROZANOLIXIZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 480 | 26800695 |
US |
52 | 2 |
Autoimmune thyroiditis, Cervix carcinoma, Cerebrovascular accident, Hypothyroidism, Chronic hepatitis C, Type V hyperlipidaemia, Hypoxia, Influenza, Cystitis, Mitral valve prolapse, Thyroid adenoma, Migraine, Nausea, |
||||
ETANERCEPT, DENOSUMAB, HYDROQUINONE, HYDROXYZINE, LEVOTHYROXINE SODIUM, PROPRANOLOL HYDROCHLORIDE, |
||||
| 481 | 26801056 |
CO |
2 | |
Influenza, |
||||
DENOSUMAB, |
||||
| 482 | 26801209 |
CA |
2 | |
Bacterial test positive, Influenza, |
||||
ECULIZUMAB, ECULIZUMAB, ERGOCALCIFEROL, |
||||
| 483 | 26801246 |
CA |
37 | 2 |
Hidradenitis, Influenza, |
||||
INFLIXIMAB, INFLIXIMAB, |
||||
| 484 | 26801504 |
|||
Influenza, |
||||
C1 ESTERASE INHIBITOR RECOMBINANT, EPINEPHRINE, ADRENALINUM, CELECOXIB, LEVOCETIRIZINE DIHYDROCHLORIDE, TEMAZEPAM, PREGABALIN, ALBUTEROL SULFATE, ALPRAZOLAM, FLUTICASONE PROPIONATE, ERGOCALCIFEROL, AZELASTINE HYDROCHLORIDE, AZELASTINE, ICATIBANT, MONTELUKAST SODIUM, MONTELUKAST, GABAPENTIN, FAMOTIDINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, MEDROXYPROGESTERONE ACETATE, ONDANSETRON HYDROCHLORIDE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, |
||||
| 485 | 26801820 |
US |
||
Influenza, Bronchitis, |
||||
ASFOTASE ALFA, |
||||
| 486 | 26801877 |
US |
1 | |
Influenza, Illness, Product dose omission issue, |
||||
RAVULIZUMAB, |
||||
| 487 | 26802532 |
US |
2 | |
Influenza, |
||||
BRINZOLAMIDE/BRIMONIDINE TARTRATE, |
||||
| 488 | 26802643 |
US |
2 | |
Anaphylactic reaction, Myasthenia gravis, Pneumonia aspiration, Blindness transient, Blood pressure decreased, Influenza, Headache, |
||||
ECULIZUMAB, HUMAN IMMUNOGLOBULIN G, |
||||
| 489 | 26802763 |
US |
73 | 1 |
Fluid retention, Weight decreased, Headache, Nausea, Pain in extremity, Back pain, Non-cardiac chest pain, Myalgia, Oropharyngeal pain, Blood pressure increased, Off label use, Muscle spasms, Pain, Influenza, Lymphoedema, Pharyngitis, Abdominal distension, |
||||
SELEXIPAG, SELEXIPAG, SELEXIPAG, TREPROSTINIL, INSULIN ASPART, ALBUTEROL SULFATE, OXYGEN, 0XYGEN, CLOPIDOGREL, TADALAFIL, RIVAROXABAN, LACTULOSE, SIMVASTATIN, TORSEMIDE, LOSARTAN, |
||||
| 490 | 26802879 |
US |
61 | 1 |
Localised infection, Influenza, Device issue, |
||||
RISANKIZUMAB-RZAA, |
||||
| 491 | 26803184 |
EU |
74 | 1 |
Chronic kidney disease, Neutropenia, Diabetes mellitus, Spinal pain, Pain, Skin papilloma, Back pain, Hyponatraemia, Nausea, Decreased appetite, Influenza, |
||||
LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, DARATUMUMAB, DARATUMUMAB, DARATUMUMAB, DARATUMUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 492 | 26803508 |
EU |
46 | 2 |
Pneumocystis jirovecii infection, Retroperitoneal cancer, Condition aggravated, Campylobacter bacteraemia, Immunodeficiency, Candida infection, Retroperitoneal mass, Mucosal inflammation, Respiratory tract infection, COVID-19, Escherichia urinary tract infection, Retroperitoneal lymphadenopathy, Blood immunoglobulin M decreased, Blood immunoglobulin A decreased, Anaemia, Viral infection, Fungal infection, Serum ferritin decreased, Acute sinusitis, Vascular purpura, Blood immunoglobulin G decreased, Clostridium test positive, Influenza, Lymphadenopathy, |
||||
RITUXIMAB, |
||||
| 493 | 26806240 |
5 | 2 | |
Therapy interrupted, Dehydration, Gastrointestinal motility disorder, Influenza, Pneumonia, |
||||
BARICITINIB, |
||||
| 494 | 26793981 |
CA |
1 | |
Pneumonia, Influenza, Wheezing, Dyspnoea, |
||||
BENRALIZUMAB, BENRALIZUMAB, DOXYCYCLINE, DOXYCYCLINE HYCLATE, ALBUTEROL SULFATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 495 | 26794028 |
32 | ||
Streptococcal infection, Viral infection, Influenza, Gastroenteritis viral, |
||||
BIMEKIZUMAB, |
||||
| 496 | 26794079 |
US |
48 | 2 |
Pneumonia, Influenza, Fungal infection, Bronchitis, |
||||
DUPILUMAB, |
||||
| 497 | 26794480 |
CA |
76 | 2 |
Dyspnoea, Croup infectious, Influenza, |
||||
BENRALIZUMAB, BENRALIZUMAB, FLUTICASONE FUROATE, ALBUTEROL SULFATE, ROSUVASTATIN, MONTELUKAST, |
||||
| 498 | 26795310 |
CA |
67 | |
SARS-CoV-2 test positive, Antibiotic therapy, Anxiety, Abdominal pain upper, Fatigue, Heart rate increased, Ill-defined disorder, Oropharyngeal pain, Back pain, Hypertension, Influenza, Off label use, |
||||
RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, PREDNISONE, PREDNISONE, LORAZEPAM, LORAZEPAM, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, |
||||
| 499 | 26795527 |
US |
66 | 1 |
Pneumonia, Influenza, |
||||
DUPILUMAB, |
||||
| 500 | 26795851 |
CA |
74 | 2 |
Pneumonia, Parainfluenza virus infection, Nasopharyngitis, Influenza, Diarrhoea, |
||||
SECUKINUMAB, SECUKINUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
